Head and Neck Cancer Clinical Trials

A listing of Head and Neck Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1095 clinical trials
The Effect of Hyperbaric Oxygen Treatment in Patients With Osteoradionecrosis.

Osteoradionecrosis (ORN) is a severe delayed radiation-induced injury that can occur in patients whom have been subjected to radiotherapy for head and neck cancer. Hyperbaric oxygen treatment

  • 0 views
  • 28 Jun, 2021
  • 2 locations
Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

2 randomized controlled trial is to determine the optimal dosage and effectiveness of intratympanic NAC injection in reducing hearing loss in head & neck cancer patients receiving cisplatin

  • 3 views
  • 23 Sep, 2021
  • 1 location
IORT in Local Advanced Laryngocarcinoma

radiotherapy (IORT) in head and neck cancer has been demonstrated in multiple institutional (3-5) studies to optimize local control. It is still unclear whether IORT can improve the local control and have

  • 0 views
  • 26 Jan, 2021
  • 1 location
Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy

enrolled in the trial: Non-Small Cell Lung Cancer (NSCLC), Head and neck cancer, Melanoma, Bladder cancer, Other tumor types when Immuno-Oncology agent

  • 10 views
  • 26 Jan, 2021
  • 2 locations
Concurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage III NSCLC

Combination treatment of Durvalumab with chemoradiotherapy is ongoing for head/neck cancer, renal cell carcinoma, melanoma, and non-small cell lung cancer (NCT02318771) and pancreatic cancer

  • 0 views
  • 23 Jan, 2021
  • 1 location
Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC

, either in head and neck cancer, esophageal cancer, or esophagogastric junction adenocarcinoma. However, its efficacy should be further investigated in larger prospective trials and little is known about

  • 0 views
  • 23 Jan, 2021
  • 1 location
NPC - AXEL Study : Axitinib-Avelumab

Nasopharyngeal cancer (NPC) is the most common head and neck cancer in South China and South East Asia. Worldwide, there are 80,000 incident cases and 50,000 deaths annually. In Hong Kong, NPC

  • 0 views
  • 14 May, 2021
  • 1 location
Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer

This is a Phase 2 study of enoblituzumab combined with either retifanlimab or tebotelimab administered as first-line treatment to patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

squamous cell carcinoma
metastatic squamous cell carcinoma
measurable disease
primary tumor
carcinoma
  • 1 views
  • 22 Sep, 2021
  • 18 locations
DAHANCA 35: Proton Versus Photon Therapy for Head-neck Cancer

Patients with squamous cell carcinoma of the pharynx or larynx and an anticipated benefit of proton radiotherapy in reducing the risk of late dysphagia or xerostomia are randomized to proton or photon radiotherapy (2:1)

carcinoma
squamous cell carcinoma
  • 0 views
  • 25 Jan, 2021
  • 7 locations
Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.

The aim of this study is to determine whether para-aortic lymph nodes(No.16) should be included in the lymphadenectomy during the pancreatoduodenectomy in order to improve the long-term survival of patients with pancreatic head ductal adenocarcinoma.

pancreaticoduodenectomy
  • 0 views
  • 19 Mar, 2021
  • 1 location